drugset / Trial / NCT00290940

Evaluation of Glucose Lowering Effect, Safety and Tolerability of CS-917

NCT00290940

Phase 2 Completed 400 enrolled Daiichi Sankyo
RandomizedParallel-groupDouble-blindTreatment

Summary

This study will compare glucose lowering with CS-917 compared to placebo after 3 months of treatment

Timeline

Start
2006-01
Primary completion
Completion
2007-04

Drugs

EvaluationDrugModalityDoseRoute
Subject CS-917 Unknown
Background Metformin Small molecule
Background Pioglitazone Small molecule